RT @MeralElRamahiMD: *ï¸â£CT-P13=1st monoclonal biosimilar to infliximab (IFX) âï¸ReFLECT: 1370 French pts (142 RA
Tweet Content
*️⃣CT-P13=1st monoclonal biosimilar to infliximab (IFX)
⭐️ReFLECT: 1370 French pts (142 RA, 411 axSpA, 96 PsA)
→2 groups: IFX-naïve starting CT-P vs switching from IFX to CT-P
*️⃣CT-P13 induced improvement in IFX-naïve & maintained dz in pts switched
Abst#0817 #ACR21 @RheumNow https://t.co/bASmGvhuIS
Show on Archive Page
On
Display in Search Results
On
PDQ
Off